What is Pancreatic cancer resectability? Why is early detection important?
Resectable pancreatic cancer means being able to be removed surgically. Usually, this means that the tumor is confined to areas typically removed surgically. Unresectable or inoperable means it is unable to be removed with surgery. The only possibly curative treatment for pancreatic cancer is surgical resection. It is critical to diagnose tumors at an early stage, when they are resectable, to improve the prognosis of this disease.
What is a fluid or liquid biopsy? Why pancreatic cancer early detection find liquid biopsies helpful?
A liquid biopsy is a test done on a blood sample to look for cancer cells from a tumor circulating in the blood or for pieces of DNA from tumor cells in the blood. A liquid biopsy may be used to help find cancer at an early stage. It may also allow plan treatment or determine how well treatment is working or if cancer has come back. Taking multiple blood samples over time may also help doctors understand what kind of molecular changes are taking place in a tumor. Liquid biopsies are of particular relevance in clinical settings because of their minimal invasiveness, repeated sampling, and comprehensive depiction of full or multi-site tumor bulks compared to tissue samples. Many studies have established the possibility of liquid biopsies in pancreatic cancer, demonstrating that liquid biopsies can detect early emergency of pancreatic cancer cells, residual illness, and recurrence. (Sources: science.gov , moffitt.org) See other Early Detection FAQs & Terminology
PanKind is the critical lead funder of innovative research projects focused on early detection working towards a breakthrough to triple survival rates.